BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025)

BioNexus Gene Lab (BGLC) reported Work In Process of $190588.0 for Q3 2025, up 0.95% sequentially from $188797.0 in Q4 2024.

BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025) Analysis & Trends

BioNexus Gene Lab (BGLC) has 2 years of Work In Process data on file, last reported at $190588.0 in Q3 2025.

  • For the quarter ending Q3 2025, Work In Process changed N/A year-over-year to $190588.0; the trailing twelve-month figure through Sep 2025 stood at $190588.0 (changed N/A YoY), and the FY2024 full-year result was $188797.0, changed N/A from the prior year.
  • Work In Process advanced to $190588.0 in Q3 2025, from $188797.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $190588.0 in Q3 2025 to a low of $188797.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 237.95 Bn 233.99 Bn 4.26 Bn
2 Sherwin Williams 78.17 Bn 77.95 Bn 2.78 Bn
3 Ecolab 76.02 Bn 75.37 Bn 1.85 Bn
4 Air Products & Chemicals 66.38 Bn 65.43 Bn 987.40 Mn
5 Ppg Industries 26.02 Bn 24.40 Bn 1.66 Bn
6 LyondellBasell Industries 22.51 Bn 19.87 Bn 701.00 Mn
7 Chemical & Mining Co Of Chile 19.70 Bn 15.83 Bn 778.60 Mn
8 International Flavors & Fragrances 19.51 Bn 18.95 Bn 1.02 Bn
9 DuPont de Nemours 18.80 Bn 18.71 Bn 602.00 Mn
10 BioNexus Gene Lab 2.82 Mn -1.14 Mn -790.00

Historic Data

Download Data
DateValue
Sep 30, 2025 190,588.00
Dec 31, 2024 188,797.00